Pharmaceutical giants Daiichi Sankyo and Merck & Co., known globally as MSD, have officially announced the voluntary withdrawal of their…
Read More
FDA Approves Eli Lilly’s Once-Weekly Basal Insulin Onswik for Type 2 Diabetes Following Robust Phase III Clinical Trials
The United States Food and Drug Administration has officially granted marketing authorization to Eli Lilly and Company for Onswik, chemically…
Read More
The BioTechniques Image Competition 2026 Reveals Its Finalists Following Unprecedented Global Submissions and A Three-Way Tie For Tenth Place
The intersection of advanced scientific methodology and visual artistry has once again captured the attention of the global research community…
Read More
Biomedical Engineers Develop Injectable Biomaterial to Facilitate Brain Repair Following Ischemic Stroke
The aftermath of an ischemic stroke has long represented a clinical dead-end in modern neurology; once brain tissue dies due…
Read More
UK Recommends Routine Meningitis B Vaccination for Adolescents Following Data Review
The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has put forth a significant recommendation for the introduction of a…
Read More
J&J raises FY26 outlook following positive Q2 – Pharmaceutical Technology
Johnson & Johnson (J&J) announced robust second-quarter (Q2) revenues totaling approximately $25.3 billion, marking a significant 6.6% increase year-over-year (YoY).…
Read More
Biogen Pauses or Terminates Investment in Most of Apellis’ Legacy Research Programs Following $5.6 Billion Acquisition
Three months after Biogen finalized its substantial $5.6 billion acquisition of Apellis Pharmaceuticals, a significant shift in research and development…
Read More
Brinsupri Poised to Redefine Bronchiectasis Treatment Standards Following Robust ATS 2026 Showcase
The landscape of non-cystic fibrosis bronchiectasis (NCFB) treatment is undergoing a significant transformation with the emergence of Brinsupri (brensocatib), a…
Read More
Novo Nordisk’s Wegovy Poised for Significant European Expansion Following Positive CHMP Opinions on Oral and High-Dose Injectable Formulations
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…
Read More
CERN Researchers Identify Potential Cracks in the Standard Model Following Unprecedented Observations at the Large Hadron Collider
Recent findings from ongoing research at the Large Hadron Collider (LHC) at CERN in Geneva suggest that the scientific community…
Read More
